Categories
Tags
Authors: McCoy J, Goren A, Cadegiani FA, Vano-Galvan S, Kovacevic M, Situm M et al. PMID: 34350193 PMCID: PMC8326462 DOI: 10.3389/fmed.2021.668698 Abstract Antiandrogens have demonstrated a protective effect for COVOD-19 patients in observational and interventional studies. The goal of this study was to determine if proxalutamide, an androgen receptor antagonist, could [...]
Categories: I-CARE Early Covid, MATH+
Tags: COVID-19, Proxalutamide
Authors: Cadegiani FA, McCoy J, Zimerman A, Mirza FN, Barros RN doi: https://doi.org/10.1101/2021.06.22.21259318 Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity is mediated by the androgen-promoted protease, transmembrane protease, serine 2 (TMPRSS2). Previously, we have shown that treatment with proxalutamide, a non-steroidal androgen receptor antagonist, accelerates viral clearance and [...]
Categories: I-CARE Early Covid, MATH+
Tags: COVID-19, Proxalutamide